- Home
- MERC vs CERS Comparison
MERC vs CERS Comparison
Compare MERC & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MERC
- CERS
- Stock Information
- Founded
- MERC 1968
- CERS 1991
- Country
- MERC Canada
- CERS United States
- Employees
- MERC N/A
- CERS N/A
- Industry
- MERC Paper
- CERS EDP Services
- Sector
- MERC Basic Materials
- CERS Technology
- Exchange
- MERC Nasdaq
- CERS Nasdaq
- Market Cap
- MERC 271.5M
- CERS 255.0M
- IPO Year
- MERC 1987
- CERS 1997
- Fundamental
- Price
- MERC $3.08
- CERS $1.23
- Analyst Decision
- MERC Hold
- CERS Strong Buy
- Analyst Count
- MERC 3
- CERS 2
- Target Price
- MERC $4.67
- CERS $3.50
- AVG Volume (30 Days)
- MERC 554.4K
- CERS 1.1M
- Earning Date
- MERC 10-30-2025
- CERS 10-29-2025
- Dividend Yield
- MERC 9.74%
- CERS N/A
- EPS Growth
- MERC N/A
- CERS N/A
- EPS
- MERC N/A
- CERS N/A
- Revenue
- MERC $1,951,044,000.00
- CERS $192,510,000.00
- Revenue This Year
- MERC N/A
- CERS $30.03
- Revenue Next Year
- MERC $13.33
- CERS $9.37
- P/E Ratio
- MERC N/A
- CERS N/A
- Revenue Growth
- MERC N/A
- CERS 13.25
- 52 Week Low
- MERC $2.59
- CERS $1.12
- 52 Week High
- MERC $8.28
- CERS $2.24
- Technical
- Relative Strength Index (RSI)
- MERC 43.51
- CERS 44.31
- Support Level
- MERC $3.07
- CERS $1.17
- Resistance Level
- MERC $3.31
- CERS $1.35
- Average True Range (ATR)
- MERC 0.13
- CERS 0.07
- MACD
- MERC 0.00
- CERS -0.00
- Stochastic Oscillator
- MERC 11.76
- CERS 22.22
About MERC Mercer International Inc.
Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The company has a geographical presence in the USA, Germany, China, and Other countries, where the majority of revenue is generated from the USA. The majority of the revenue is generated from the Pulp segment.
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.